Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Benfotiamine in Diabetic Nephropathy

This study has been completed.
Sponsor:
Collaborators:
Isala
Wörwag Pharma GmbH & Co. KG
Predictions Network
Information provided by:
University Medical Centre Groningen
ClinicalTrials.gov Identifier:
NCT00565318
First received: November 28, 2007
Last updated: November 13, 2009
Last verified: November 2009